It was another busy week for Australia’s top brokers. This has led to the release of a number of broker notes.
Three broker buy ratings that you might want to know more about are summarised below. Here’s why brokers think these ASX shares are in the buy zone:
Breville Group Ltd (ASX: BRG)
According to a note out of Macquarie, its analysts have retained their outperform rating on this appliance manufacturer’s shares with a trimmed price target of $37.10. Macquarie has been looking at industry data and believes it is favourable for Breville and suggests that it could be outperforming peers. The broker highlights that this is being driven by growth from its coffee business, as well as new products and new markets. Overall, Macquarie believes this leaves Breville well-placed for annual growth of 10%+ through to FY 2028. The Breville share price ended the week at $26.28.
Cochlear Ltd (ASX: COH)
A note out of UBS reveals that its analysts have retained their buy rating and $302.00 price target on this hearing solutions company’s shares. UBS believes that recent share price weakness has created an attractive buying opportunity for investors. This is especially the case given how the broker believes Cochlear’s new next-generation cochlear implant platform, Nexa, will underpin a strong earnings recovery. The broker believes that with limited competition, Cochlear is well-placed to win market share. And while there are concerns over gene therapies, UBS doesn’t believe this is something that will impact its near term performance. The Cochlear share price was fetching $170.23 at Friday’s close.
Liontown Ltd (ASX: LTR)
Another note out of UBS reveals that its analysts have retained their buy rating and $2.20 price target on this lithium miner’s shares. UBS is feeling positive about lithium and believes now could be a good time for investors to consider a position in the industry. This is because UBS sees potential for another upcycle for lithium prices. It suspects that surging oil prices and supply disruptions caused by the war in the Middle East could be good news for lithium. It feels that the impact this is having on the fuel market could lead to increased demand for electric vehicles and lithium for batteries. In fact, the broker sees potential for the spodumene price to reach US$4,000 per tonne by the end of the year. The Liontown share price ended the week at $1.76.
The post Top brokers name 3 ASX shares to buy next week appeared first on The Motley Fool Australia.
Should you invest $1,000 in Breville Group Limited right now?
Before you buy Breville Group Limited shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Breville Group Limited wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys…
* Returns as of 20 Feb 2026
.custom-cta-button p {
margin-bottom: 0 !important;
}
More reading
- ASX 200 mining shares rebound after March sell-off creates opportunities
- 3 high-quality Australian stocks I would buy and hold for a decade
- 5 oversold ASX 200 shares to buy according to Wilsons
- ASX lithium shares ‘compelling’ as top broker adjusts ratings
- Brokers name 3 ASX shares to buy right now
Motley Fool contributor James Mickleboro has positions in Cochlear. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Cochlear and Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended Cochlear. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.